Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Homatropine methylbromide 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Some |
|
Homatropine methylbromide 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Some |
|
Homatropine methylbromide + hydrocodone bitartrate 1.5mg/5mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Some |
|
Homatropine methylbromide + hydrocodone bitartrate 1.5mg/5mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Some |
|
Homatropine methylbromide 1.5 mg and hydrocodone bitartrate 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Some |
|
Homatropine methylbromide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Some |
|
Product containing homatropine methylbromide and hydrocodone bitartrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Some |
|
Homatropine hydrobromide 2% preservative-free eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Some |
|
Homatropine hydrobromide 0.125% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Some |
|
Homatropine hydrobromide 0.25% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Some |
|
Homatropine hydrobromide 0.5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Some |
|
Homatropine hydrobromide 1% preservative-free eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Some |
|
Homatropine hydrobromide 2% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Some |
|
Homatropine hydrobromide 20 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Some |
|
Homatropine hydrobromide 10 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Some |
|
Homatropine hydrobromide 5% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Some |
|
Homatropine methylbromide 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Some |
1 |
Homatropine methylbromide 5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Homatropine methylbromide |
Inferred relationship |
Some |
1 |
Homatropine methylbromide 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Some |
1 |
Homatropine methylbromide 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Homatropine methylbromide |
Inferred relationship |
Some |
1 |
Homatropine methylbromide 1.5 mg and hydrocodone bitartrate 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Some |
2 |
Homatropine methylbromide 1.5 mg and hydrocodone bitartrate 5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Homatropine methylbromide |
Inferred relationship |
Some |
2 |
Homatropine methylbromide 5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Homatropine methylbromide |
Inferred relationship |
Some |
1 |
Homatropine methylbromide 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Homatropine methylbromide |
Inferred relationship |
Some |
1 |
Homatropine methylbromide 1.5 mg and hydrocodone bitartrate 5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Homatropine methylbromide |
Inferred relationship |
Some |
2 |